Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The New European Surgical Academy (NESA) is an international, interdisciplinary surgical organization founded in 2004 and headquartered in Berlin, Germany. Under the leadership of President Michael Stark, the academy focuses on re-evaluating and optimizing surgical procedures across disciplines such as gynecology, obstetrics, urology, and oncology. NESA is renowned for its work in minimally invasive surgery, specifically Natural Orifice Surgery (NOS) and the Misgav Ladach method for Caesarean sections. The organization facilitates global knowledge transfer, particularly to resource-limited regions, and manages innovative research initiatives like the VIEZION project, which integrates oncology treatments with regenerative medicine. NESA also organizes the annual NESA Days conference to promote interdisciplinary surgical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New European Surgical Academy.